Abstract
Inside Precision MedicineVol. 9, No. 2 MRD and Clinical TrialsMRD: The Future Foundation of Solid Tumor Trials?The terms minimal residual disease, measurable residual disease, and molecular residual disease, interchangeably referred to as MRD, denote what is left after cancer treatment with curative intent. Originally used to monitor patients with hematologic malignancies, MRD is becoming increasingly important in the field of solid tumor oncology because of its correlation with disease outcomes.Laura CowenLaura CowenLaura Cowen is a freelance medical journalist who has been covering healthcare news for over 10 years. Her main specialties are oncology and diabetes, but she has written about subjects ranging from cardiology to ophthalmology and is particularly interested in infectious diseases and public health.Search for more papers by this authorPublished Online:14 Apr 2022https://doi.org/10.1089/ipm.09.02.03AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 9Issue 2Apr 2022 InformationCopyright © GEN PublishingTo cite this article:Laura Cowen.MRD: The Future Foundation of Solid Tumor Trials?.Inside Precision Medicine.Apr 2022.12-13, 16.http://doi.org/10.1089/ipm.09.02.03Published in Volume: 9 Issue 2: April 14, 2022PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
